Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm: A case report

Interventional Neuroradiology

Volumn 8, Issue 4, 2002, Pages 409-415

  Song, D K ^a   Harrigan, M R ^a   Deveikis, J P ^a   McGillicuddy, John E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Angioplasty; Autoregulation; Cerebral blood flow; Ischemia; Vasospasm

Indexed keywords

DOBUTAMINE; DOPAMINE; NIMODIPINE; XENON;

ADULT; ANGIOPLASTY; ARTICLE; AUTOREGULATION; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN STEM; BRAIN VASOSPASM; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMODILUTION; HUMAN; HYPERDYNAMIC THERAPY; HYPERTENSION; HYPERVOLEMIA; HYPOTENSION; PATIENT MONITORING; POSTERIOR COMMUNICATING ARTERY; PRESSOR RESPONSE; QUANTITATIVE ANALYSIS; SURGICAL EQUIPMENT; SYSTOLIC BLOOD PRESSURE;

EID: 0036987788     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Adams H, Kassell N et al: Predicting cerebral ischemia after aneurysmal subarachnoid haemorrhage: Influences of clinical condition, CT results, and antifibrinolytic therapy. Neurology 37: 1586-1591, 1987.
2. Charpentier C, Audibert G et al: Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid haemorrhage. Stroke 30: 1402-1408, 1999.
3. Kassell N, Torner J et al: The International Cooperative Study on the Timing of Aneursym Surgery. Part 2: Surgical results. J Neurosurg 73: 37-47, 1990.
4. Mayberg M, Batjer H, Dacey R: Guidelines for the management of aneurysmal subarachnoid haemorhage. Stroke 25: 2315-2328, 1994.
5. Darby J, Yonas H et al: Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid haemorrhage. J Neurosurg 80: 857-864, 1994.
6. Ishii R: Regional cerebral blood flow in patients with ruptured intracranial aneurysms. J Neurosurg 50: 587-594, 1979.
7. Voldby B, Enevoldsen E, Jensen F: Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 62: 59-67, 1985.
8. Yundt K, Grubb R et al: Autoregulatory vasodilation of parenchymal vessels is impaired during vasospasm. J Cereb Blood Flow Metab 18: 419-424, 1998.
9. Awad I, Carter L et al: Clinical vasospasm after subarachnoid haemorrhage: Response to hypervolemic haemodilution and arterial hypertension. Stroke 18: 365-372, 1987.
10. Ohtaki M, Tranmer B: Hyperdynamic therapy for focal cerebral ischemia of rats: Use of colloidal volume expansion and dobutamine. Surg Neurol 40: 131-137, 1993.
11. Origitano T, Wascher T et al: Sustained increased cerebral blood flow with prophylactic hypertensive hyperolemic haemodilution ("triple-H" therapy) after subarachnoid haemorrhage. Neurosurgery 27: 729-740, 1990.
12. Bejjani G, Bank W et al: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid haemorrhage. Neurosurgery 42: 979-987, 1998.
13. Firlik A, Kaufmann A et al: Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid haemorrhage. J Neurosurg 86: 830-839, 1997.
14. Polin R, Coenen V et al: Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Neurosurg 92: 284-290, 2000.
15. Dorsch N: The effect and management of delayed vasospasm after subarachnoid haemorrhage. Neurol Med Chir Suppl (Tokyo) 38: 156-160, 1998.
16. Voldby B, Enevoldsen E, Jensen F: Regional CBF, intraventricular pressure and cerebral metabolism in patients with ruptured intracranial aneurysms. J Neurosurg 62: 48-58, 1985.
17. Bergvall U, Steiner L, Forster D: Early pattern of circulation disturbances following subarachnoid haemorrhage. Neuroradiology 5: 24-32, 1973.
18. Schneck S, Kricheff I: Intracranial aneurysm rupture, vasospasm and infarction. Arch Neurol 11: 668-680, 1964.
19. Fukui M, Johnson D et al: Xe/CT cerebral blood flow evaluation of delayed symptomatic cerebral ischemia after subarachnoid haemorrhage. Am J Neuroradiol 13: 265-270, 1992.
20. Mayberg M: Cerebral Vasospasm. Neurosurg Clin N Am 9: 615-627, 1998.
21. Tuoho H, Ueda H: Disturbance of autoregulation in patients with ruptured intracranial aneurysms: Mechanism of cortical and motor dysfunction. Surg Neurol 42: 57-64, 1994.
22. Keaney N, McDowall D et al: The effects of profound hypotension induced with sodium nitroprusside on cerebral blood flow and metabolism in the baboon. Br J Anaesth 45: 639, 1973.
23. Johnson D, Stringer W et al: Stable xenon CT cerebral blood flow imaging: Rationale for and role in clinical decision making. Am J Neuroradiol 12: 201-213, 1991.
24. McKhann G, Roux PL: Perioperative and intensive care unit care of patients with aneurysmal subarachnoid haemorrhage. Neurosurg Clin N Am 9: 595-613, 1998.
25. Rasmussen G, Hauerberg J et al: Cerebral blood flow autoregulation in experimental subarachnoid haemorrhage in rat. Acta Neurochir (Wien) 119: 128-133, 1992.
26. Steiner LLJ, Zwetnow N: Cerebral blood flow and metabolism in the acute phase of experimental subarachnoid bleed. Zentralbl Neurochir 39: 223-230, 1978.
27. Boisvert D, Overton T et al: Cerebral arterial responses to induced hypertension following subarachnoid haemorrhage in the monkey. J Neurosurg 49: 75-83, 1978.
28. Fein J, Boulos R: Local cerebral blood flow in experimental middle cerebral artery vasospasm. J Neurosurg 39: 337-347, 1973.
29. 2 and autoregulation following experimental subarachnoid haemorrhage. J Neurol Sci 17: 15-22, 1972.
30. Kamiya K, Kuyama H, Symon L: An experimental study of the acute stage of subarachnoid haemorrhage. J Neurosurg 59: 917-924, 1983.
31. Kuyama K, Ladds A et al: An experimental study of acute subarachnoid haemorrhage in baboons: Changes in cerebral blood volume, blood flow, electrical activity and water content. J Neurol Neurosurg Psychiatry 47: 354-364, 1984.
32. Jakubowski J, Bell B et al: A primate model of subarachnoid haemorrhage: Change in regional cerebral bllod flow, autoregulation carbon dioxide reactivity, and central conduction time. Stroke 13: 601-611, 1982.
33. Pickard J, Boivert D et al: Late effects of subarachnoid haemorrhage to drug-induced changes in arterial blood pressure. J Neurol Neurosurg Psychiatry 42: 899-903, 1979.
34. Takeuchi H, Handa Y et al: Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachbnoid haemorrhage in primates. Neurosurgery 28: 41-48, 1991.
35. Lang E, Diehl R, Mehdorn H: Cerebral autoregulation testing after aneurysmal subarachnoid haemorrhage: The phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med 29: 158-163, 2001.
36. Kassell N, Peerless S et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11: 337-343, 1982.
37. Muizelaar J, Becker D: Induced hypertension for the treatment of cerebral ischemia after subarachnoid haemorrhage. Surg Neurol 25: 317-325, 1986.
38. Otsubo H, Takemae T et al Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) 103: 18-26, 1990.
39. Yonas H, Sekhar L et al: Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 24: 368-372, 1989.
40. Harris R, Branston N et al: The effects of a calcium channel antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13: 759-766, 1982.
41. Hauerberg J, Rasmussen G et al: The effect of nimodipine on autoregulation of cerebral blood flow after subarachnoid haemorrhage in rat. Acta Neurochir (Wien) 132: 98-103, 1995.
42. Dorsch N, Branston N et al: An experimental study of the effect of nimodipione in primate subarachnoid haemorrhage. Acta Neurochir (Wien) 99: 65-75, 1989.
43. Allen G, Ahn H et al: Cerebral arterial spasm, a controlled trial of nimodipine in patients with subarachnoid haemorrhage. N Engl J Med 308: 619-624, 1983.
44. Barker F, Ogilvy C: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid haemorrhage: A metanalysis. J Neurosurg 84: 405-414, 1996.
45. Feigin V, Rinkel G et al: Calcium antagonists in patients with aneurysmal subarachnoid haemorrhage. Neurology 50: 876-883, 1998.
46. Neil-Dwyer G, Mee E et al: Early intervention with nimodipine in subarachnoid haemorrhage. European Heart Journal 8 (suppl K): 41-47, 1987.
47. Petruk K, West M et al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68: 505-517, 1988.
48. Pickard J, Murray G et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298: 636-642, 1989.
49. Tettenborn D, Dycka J: Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid haemorrhage. Stroke 21 (suppl IV): 85-89, 1990.
50. Altura B, Gebrewold A, Lassoff S: Biphasic responsiveness of rat pial arterioles to dopamine: Direct observations on the microcirculation. British Journal of Pharmacology 69: 543-544, 1980.
51. Edvinsson L, Hardebo J et al: Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists. Advances in Neurology 20: 85-96, 1978.
52. Ihara I, Kikuchi H: The effect of low dose dopamine on CBF in patients with subarachnoid haemorrhage. No To Shinkei 38: 647-654, 1986.
53. Busija D, Leffler C: Effects of dopamine on pial arteriolar diameter and CSF prostanoid levels in piglets. J Cereb Bllod Flow Metab 9: 264-267, 1989.